These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 16842460)
1. Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease. Hindorf U; Lindqvist M; Hildebrand H; Fagerberg U; Almer S Aliment Pharmacol Ther; 2006 Jul; 24(2):331-42. PubMed ID: 16842460 [TBL] [Abstract][Full Text] [Related]
2. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease. Kwan LY; Devlin SM; Mirocha JM; Papadakis KA Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898 [TBL] [Abstract][Full Text] [Related]
3. Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients. Gisbert JP; Niño P; Rodrigo L; Cara C; Guijarro LG Am J Gastroenterol; 2006 Dec; 101(12):2769-76. PubMed ID: 17026564 [TBL] [Abstract][Full Text] [Related]
4. A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity. Roblin X; Peyrin-Biroulet L; Phelip JM; Nancey S; Flourie B Am J Gastroenterol; 2008 Dec; 103(12):3115-22. PubMed ID: 19086961 [TBL] [Abstract][Full Text] [Related]
5. Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold. Gardiner SJ; Gearry RB; Begg EJ; Zhang M; Barclay ML Clin Gastroenterol Hepatol; 2008 Jun; 6(6):654-60; quiz 604. PubMed ID: 18467186 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of thiopurine therapy in paediatric IBD patients. De Ridder L; Van Dieren JM; Van Deventer HJ; Stokkers PC; Van der Woude JC; Van Vuuren AJ; Benninga MA; Escher JC; Hommes DW Aliment Pharmacol Ther; 2006 Apr; 23(8):1137-41. PubMed ID: 16611274 [TBL] [Abstract][Full Text] [Related]
7. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study. Gisbert JP; Luna M; Maté J; González-Guijarro L; Cara C; Pajares JM Hepatogastroenterology; 2006; 53(69):399-404. PubMed ID: 16795981 [TBL] [Abstract][Full Text] [Related]
8. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease? Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442 [TBL] [Abstract][Full Text] [Related]
9. Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome. Shah JA; Edwards CM; Probert CS Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):169-73. PubMed ID: 18301295 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease. Winter J; Walker A; Shapiro D; Gaffney D; Spooner RJ; Mills PR Aliment Pharmacol Ther; 2004 Sep; 20(6):593-9. PubMed ID: 15352906 [TBL] [Abstract][Full Text] [Related]
11. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease. Cao Q; Zhu Q; Shang Y; Gao M; Si J Digestion; 2009; 79(1):58-63. PubMed ID: 19252404 [TBL] [Abstract][Full Text] [Related]
12. Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease. Ansari A; Patel N; Sanderson J; O'Donohue J; Duley JA; Florin TH Aliment Pharmacol Ther; 2010 Mar; 31(6):640-7. PubMed ID: 20015102 [TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients. Gilissen LP; Bierau J; Derijks LJ; Bos LP; Hooymans PM; van Gennip A; Stockbrügger RW; Engels LG Aliment Pharmacol Ther; 2005 Oct; 22(7):605-11. PubMed ID: 16181300 [TBL] [Abstract][Full Text] [Related]
14. Thiopurine S-methyltransferase genotype and the use of thiopurines in paediatric inflammatory bowel disease Greek patients. Gazouli M; Pachoula I; Panayotou I; Mantzaris G; Syriopoulou VP; Goutas N; Vlachodimitropoulos D; Anagnou NP; Roma-Giannikou E J Clin Pharm Ther; 2010 Feb; 35(1):93-7. PubMed ID: 20175817 [TBL] [Abstract][Full Text] [Related]
15. Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease. Hindorf U; Johansson M; Eriksson A; Kvifors E; Almer SH Aliment Pharmacol Ther; 2009 Mar; 29(6):654-61. PubMed ID: 19183142 [TBL] [Abstract][Full Text] [Related]